Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Current Drug Targets
|
October 2, 2015
B1-Metallo-β-Lactamases: Where Do We Stand?
Maria F Mojica, Robert A Bonomo, Walter Fast
Current Opinion in Infectious Diseases
|
October 17, 2023
Treatment approaches for severe Stenotrophomonas maltophilia infections
Maria F Mojica, Robert A Bonomo, David van Duin
The Lancet. Infectious Diseases
|
July 11, 2021
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
Maria F Mojica, Maria-Agustina Rossi, Alejandro J Vila, et al.
The Lancet. Microbe
|
May 11, 2026
Treatment strategies for imipenemase-producing Gram-negative infections: lessons from Japan
Daisuke Ono, Sohei Harada, Yoshikazu Ishii, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 8, 2025
How do I manage a patient with Stenotrophomonas maltophilia infection?
Roberta Monardo, Maria F Mojica, Marco Ripa, et al.
Microbiology Spectrum
|
September 24, 2024
Cefepime-taniborbactam demonstrates potent <i>in vitro</i> activity vs <i>Enterobacterales</i> with <i>bla</i><sub>OXA-48</sub>
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
ACS Infectious Diseases
|
October 23, 2024
Frameshift Mutations in Genes Encoding PBP3 and PBP4 Trigger an Unusual, Extreme β-Lactam Resistance Phenotype in <i>Burkholderia multivorans</i>
Maria F Mojica, Michiyoshi Nukaga, Scott A Becka, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 29, 2023
Association of COVID-19 coinfection with increased mortality among patients with <i>Pseudomonas aeruginosa</i> bloodstream infection in the Veterans Health Administration system
Leila S Hojat, Brigid M Wilson, Federico Perez, et al.
Microbiology Spectrum
|
December 23, 2025
Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying <i>bla</i><sub>OXA-48</sub>
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Examining the activity of cefepime-taniborbactam against <i>Burkholderia cepacia</i> complex and <i>Burkholderia gladioli</i> isolated from cystic fibrosis patients in the United States
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Current Drug Targets
|
October 2, 2015
B1-Metallo-β-Lactamases: Where Do We Stand?
Maria F Mojica, Robert A Bonomo, Walter Fast
Current Opinion in Infectious Diseases
|
October 17, 2023
Treatment approaches for severe Stenotrophomonas maltophilia infections
Maria F Mojica, Robert A Bonomo, David van Duin
The Lancet. Infectious Diseases
|
July 11, 2021
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
Maria F Mojica, Maria-Agustina Rossi, Alejandro J Vila, et al.
The Lancet. Microbe
|
May 11, 2026
Treatment strategies for imipenemase-producing Gram-negative infections: lessons from Japan
Daisuke Ono, Sohei Harada, Yoshikazu Ishii, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 8, 2025
How do I manage a patient with Stenotrophomonas maltophilia infection?
Roberta Monardo, Maria F Mojica, Marco Ripa, et al.
Microbiology Spectrum
|
September 24, 2024
Cefepime-taniborbactam demonstrates potent <i>in vitro</i> activity vs <i>Enterobacterales</i> with <i>bla</i><sub>OXA-48</sub>
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
ACS Infectious Diseases
|
October 23, 2024
Frameshift Mutations in Genes Encoding PBP3 and PBP4 Trigger an Unusual, Extreme β-Lactam Resistance Phenotype in <i>Burkholderia multivorans</i>
Maria F Mojica, Michiyoshi Nukaga, Scott A Becka, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
December 29, 2023
Association of COVID-19 coinfection with increased mortality among patients with <i>Pseudomonas aeruginosa</i> bloodstream infection in the Veterans Health Administration system
Leila S Hojat, Brigid M Wilson, Federico Perez, et al.
Microbiology Spectrum
|
December 23, 2025
Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying <i>bla</i><sub>OXA-48</sub>
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Examining the activity of cefepime-taniborbactam against <i>Burkholderia cepacia</i> complex and <i>Burkholderia gladioli</i> isolated from cystic fibrosis patients in the United States
Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.
Page
of 5